- Product Details
Keywords
- reasonable price of Lamivudine Intermediate – CTS
- manufacturer of 173522-96-8
- 173522-96-8
Quick Details
- ProName: reasonable price of Lamivudine Interme...
- CasNo: 173522-96-8
- Molecular Formula: C8H11N3O3·C7H6O3
- Appearance: White to off-white powder
- Application: 173522-96-8
- DeliveryTime: up to request
- PackAge: up to request
- Port: Any port in China
- ProductionCapacity: 100 Metric Ton/Year
- Purity: 99%+
- Storage: Store in cool and dry place.
- Transportation: up to request
- LimitNum: 1 Kilogram
Superiority
reasonable price of Lamivudine Intermediate – CTSmanufacturer of 173522-96-8
Product Name: | Lamivudine salicylate |
Synonyms: | (2r-cis)-4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1h)-pyrimidinone 2-hydroxybenzoate;lamivudine salicylate;2r-(Hydroxymethyl)-5(S)-Cytosin-1-Yl-1,3-Oxathiolanesalicycic Acid Salt;2R-(hydroxymethyl)-5(s)-cytosin-1-yl-[1,3]-oxathiolane salicylic acid salt (intermediate of lamivudine);2R-(HYDROXYMETHYL)-5(S)-CYTOSIN-1-YL-1,3-OXATHIOLANESALICYCIC ACID SALT (LAMIVUDINE SALICYLATE);2R-(HYDROXYMETHYL)-5(S)-CYTOSIN-1-YL-[1,3]-OXATHIOLANE SALICYLIC ACID SALT;2R-(hydroxymethyl)-5(S)-cytosin-lyl-1,3-oxothiolane salicylic acid salt (Lamivudine Salicylate);(2R, 5S) -2-(Hydroxymethyl)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane salicylate |
CAS: | 173522-96-8 |
MF: | C8H11N3O3S.C7H6O3 |
MW: | 367.38 |
EINECS: | 827-409-4 |
Product Categories: | Organic acids;(intermediate of lamivudine) |
Mol File: | 173522-96-8.mol |
1. Certificate Of Analysis (COA)
2. Material Safety Data Sheet (MSDS)
Details
reasonable price of Lamivudine Intermediate – CTSmanufacturer of 173522-96-8
LONZEAL Pharmaceuticals is a leading manufacturing company covering finished formulation, active pharmaceutical ingredients and advanced intermediates. Our products and manufacturing site have been approved and inspected by stringent drug authorities such as USFDA, WHO, China NMPA, Brazil ANVISIA and India DCGI, based on which, we have been supplying to esteemed customers globally in the past 15 years with regulatory compliance and good quality.
Our current main products cover anti-virus, anti-depression and anti-neuropathic pain areas. Lonzeal has become one of the key manufacturers in the global supply of anti-HIV drugs and is providing support to the treatment need of over 4 Million patients each year worldwide.